Clinical Trial Update: BeneFIX Drug Use Results Survey [All-Case Surveillance]

View source ↗

Summary

This clinical trial update reports the results of BeneFIX usage from an all-case surveillance study in Hemophilia B, with results posted on 2017-04-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BeneFIX (recombinant coagulation factor IX concentrate)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B | Status: COMPLETED | Results posted: 2017-04-11